France Biotech

France Biotech was founded in 1997 as an independent association, uniting the country’s leading innovative health companies and their expert partners. As a leader in health innovation working in close cooperation with public authorities in France and across Europe, France Biotech is ideally positioned to address the challenges facing the HealthTech sector, notably corporate financing, taxation on innovation and regulatory and market access-related issues. Its committees and working groups strive to identify viable solutions to create the necessary conditions for a competitive and attractive industry. Its mission is to support HealthTech start-ups and SMEs in their quest for international expansion with the capability to rapidly design and develop new innovations and get them to the point of care. Since September 2019, France Biotech has been chaired by Theranexus chairman Franck Mouthon. The association currently represents550 members.